| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 149.650 | 158.793 | 165.061 | 173.862 | 165.534 | 151.284 | 163.314 | 231.484 | 209.371 | 220.279 |
| Total Income - EUR | 150.845 | 158.793 | 165.061 | 174.283 | 165.547 | 152.816 | 166.748 | 231.872 | 209.917 | 220.551 |
| Total Expenses - EUR | 134.647 | 152.795 | 148.831 | 155.630 | 160.457 | 146.385 | 154.953 | 218.494 | 200.338 | 207.440 |
| Gross Profit/Loss - EUR | 16.198 | 5.998 | 16.230 | 18.653 | 5.090 | 6.431 | 11.795 | 13.377 | 9.579 | 13.111 |
| Net Profit/Loss - EUR | 16.198 | 5.998 | 12.061 | 17.654 | 4.207 | 1.232 | 10.122 | 11.237 | 8.046 | 11.180 |
| Employees | 10 | 11 | 11 | 7 | 7 | 6 | 7 | 7 | 7 | 5 |
Check the financial reports for the company - Ascoma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 646.236 | 648.551 | 668.150 | 659.745 | 660.680 | 659.087 | 706.378 | 728.230 | 726.986 | 746.883 |
| Current Assets | 83.374 | 98.157 | 76.300 | 63.366 | 35.255 | 21.676 | 24.043 | 14.890 | 18.763 | 28.483 |
| Inventories | 28.897 | 22.971 | 46.734 | 23.162 | 16.387 | 3.734 | 647 | 1.917 | 4.415 | 4.867 |
| Receivables | 11.941 | 8.885 | 4.698 | 5.580 | 9.600 | 11.015 | 14.672 | 2.979 | 3.502 | 2.997 |
| Cash | 42.536 | 66.301 | 24.867 | 34.625 | 9.267 | 6.926 | 8.724 | 9.994 | 10.846 | 20.620 |
| Shareholders Funds | 648.553 | 660.888 | 661.766 | 655.435 | 645.436 | 630.305 | 625.244 | 634.351 | 623.206 | 656.513 |
| Social Capital | 29.533 | 29.232 | 28.737 | 28.210 | 27.664 | 27.139 | 26.537 | 26.620 | 26.539 | 26.391 |
| Debts | 81.056 | 85.820 | 82.684 | 67.676 | 50.499 | 50.458 | 106.534 | 108.769 | 122.542 | 118.853 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5621 - 5621" | |||||||||
| CAEN Financial Year |
5621
|
|||||||||
Comments - Ascoma S.r.l.